Home > Boards > Free Zone > User's Groups > Visual Stock Resource - Weekend Scans/Stocks in Play

La Jolla Pharm reports prelim Q4 GIAPREZA net

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
starbuxsux Member Profile
 
Followed By 206
Posts 22,195
Boards Moderated 5
Alias Born 09/16/11
160x600 placeholder
starbuxsux   Saturday, 01/11/20 03:03:10 AM
Re: deadjim post# 2354
Post # of 2370 
La Jolla Pharm reports prelim Q4 GIAPREZA net sales were $7.2 million, up 71% from the three months ended December 31, 2018
8:01 AM ET 1/9/20 | Briefing.com

Vials of GIAPREZA shipped from distributors to hospitals (hospital demand) grew 74% for the three months ended December 31, 2019 as compared to the three months ended December 31, 2018 and 18% as compared to the three months ended September 30, 2019. For the twelve months ended December 31, 2019, preliminary GIAPREZA net sales were $23.1 million, up 129% from the twelve months ended December 31, 2018. La Jolla announced the commercial availability of GIAPREZA in the U.S. in March 2018.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist